GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Operating Margin %

Organon Pharma Indonesia PT (ISX:SCPI) Operating Margin % : 0.00% (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Organon Pharma Indonesia PT's Operating Income for the three months ended in . 20 was Rp0.00 Mil. Organon Pharma Indonesia PT's Revenue for the three months ended in . 20 was Rp0.00 Mil. Therefore, Organon Pharma Indonesia PT's Operating Margin % for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Organon Pharma Indonesia PT's Operating Margin % or its related term are showing as below:


ISX:SCPI's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.025
* Ranked among companies with meaningful Operating Margin % only.

Organon Pharma Indonesia PT's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Organon Pharma Indonesia PT's Operating Income for the three months ended in . 20 was Rp0.00 Mil.


Organon Pharma Indonesia PT Operating Margin % Historical Data

The historical data trend for Organon Pharma Indonesia PT's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Operating Margin % Chart

Organon Pharma Indonesia PT Annual Data
Trend
Operating Margin %

Organon Pharma Indonesia PT Quarterly Data
Operating Margin %

Competitive Comparison of Organon Pharma Indonesia PT's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Organon Pharma Indonesia PT's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organon Pharma Indonesia PT's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organon Pharma Indonesia PT's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Organon Pharma Indonesia PT's Operating Margin % falls into.



Organon Pharma Indonesia PT Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Organon Pharma Indonesia PT's Operating Margin % for the fiscal year that ended in . 20 is calculated as

Operating Margin %=Operating Income (A: . 20 ) / Revenue (A: . 20 )
= /
= %

Organon Pharma Indonesia PT's Operating Margin % for the quarter that ended in . 20 is calculated as

Operating Margin %=Operating Income (Q: . 20 ) / Revenue (Q: . 20 )
= /
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Pharma Indonesia PT  (ISX:SCPI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Organon Pharma Indonesia PT Operating Margin % Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines